Joint statement on ‘Abortion reversal’ by the Royal College of Obstetricians and Gynaecologists (RCOG), The Faculty of Sexual and Reproductive Healthcare (FSRH), the Royal College of Midwives (RCM) and the British Society of Abortion Care Providers (BSACP)
This CEU Statement provides guidance to healthcare professionals in response to a letter circulated by MSD (manufacturer of Nexplanon®) to healthcare professionals in the UK about updated guidance regarding the recommended Nexplanon® insertion site.
This report of the All Party Parliamentary Group on Sexual and Reproductive Health in the UK sets out a progress update against the recommendations of the Group's 2020 report on Access to Contraception, further to the publication of the Government's Women's Health Strategy.
Implementing the RCPCH guidance “Safeguarding guidance for children and young people under 18 accessing early medical abortion services” - Advice for Providers, Commissioners and Regulators.
This an advice document for providers, commissioners and regulators on implementing the RCPCH guidance “Safeguarding guidance for children and young people under 18 accessing early medical abortion services” (published in August 2022). It is endorsed by BSACP, FSRH and RCOG.
List of Menopause Care Principal Trainers
Essay marking criteria for the Undergraduate Student Prize Essay 2021
Download our FSRH annual report and accounts for 2021.
FSRH Clinical Guideline Launch: Progestogen-only pills certificate of attendance. You can download and print this certificate.
The FSRH CEU publishes the responses to public consultation comments on the Progestogen-only Pills Guideline.
Login to view this document. 1 CPD credit can be claimed for reading the guidance. 1 CPD credit can be claimed for answering the questions.
This summary has been written as a quick reference guide to help busy clinicians to give clear, safe advice on progestogen-only contraceptive pills. Please refer to the full 2022 FSRH Progestogen-only Pills Clinical Guideline for further information and supporting evidence for this advice. This document is written for FSRH members and requires you to log in to access it.
This guideline provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only contraceptive pills. It is intended for any healthcare professional or health service providing contraceptive care in the UK. In this version of the POP Guideline, the supporting evidence for the recommendations has been removed from the main text and located in an appendix for ease of reading. This document is written for FSRH members and requires you to log in to access it.